Vili Lampinen
Tampere, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Nucleocapsid protein enhances spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine.
Journal: BMC infectious diseases
Published: November 21, 2025
Coxsackie B1 virus-like particle vaccine modified to exclude a highly conserved immunoreactive region from the capsid induces potent neutralizing antibodies and protects against infection in mice.
Journal: Journal of biomedical science
Published: June 18, 2025
Production of norovirus-, rotavirus-, and enterovirus-like particles in insect cells is simplified by plasmid-based expression.
Journal: Scientific reports
Published: January 29, 2024
Thrombus Aspirates From Patients With Acute Ischemic Stroke Are Infiltrated by Viridans Streptococci.
Journal: Journal of the American Heart Association
Published: November 20, 2023
SpyTag/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusion.
Journal: Frontiers in cellular and infection microbiology
Published: May 03, 2023
DNA-origami-directed virus capsid polymorphism.
Journal: Nature nanotechnology
Published: October 25, 2022
Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology.
Journal: Virology
Published: November 04, 2021
Polyphenols Epigallocatechin Gallate and Resveratrol, and Polyphenol-Functionalized Nanoparticles Prevent Enterovirus Infection through Clustering and Stabilization of the Viruses.
Journal: Pharmaceutics
Published: June 29, 2021
Modular vaccine platform based on the norovirus-like particle.
Journal: Journal of nanobiotechnology
Published: August 27, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026